By Katryna Perera (November 25, 2025, 4:09 p.m. EST) — A California federal judge has granted the U.S. Securities and Exchange Commission a quick victory in its lawsuit against Vivera Pharmaceuticals, its CEO and its subsidiary Sentar Pharmaceuticals, finding they misled investors about the company's rights to key cannabinoid drug delivery technology and how investors' money would be spent…
Law360 is there, so you are too.
A Law360 subscription puts you at the center of rapidly evolving legal issues, trends and developments so you can act with speed and confidence. More than 200 articles are published daily on more than 60 topics, sectors, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Information about the judge
- Real-time alerts
- More than 450,000 archived articles available for consultation
And much more!
Check out Law360 today with a 7-day free trial.
